Enhancing cancer immunotherapy: Exploring strategies to target the PD-1/PD-L1 axis and analyzing the associated patent, regulatory, and clinical trial landscape
Article in European Journal of Pharmaceutics and Biopharmaceutics (May 2024)
The most recent citing publications are shown below. View all 50 publications that cite this research output on Dimensions.
Article in European Journal of Pharmaceutics and Biopharmaceutics (May 2024)
Article in Frontiers in Immunology (March 2024)
Article in Heliyon (November 2023)